Overview

Budesonide for Induction of Remission in Incomplete Microscopic Colitis

Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy of budesonide for the treatment of active incomplete microscopic colitis.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Falk Pharma GmbH
Treatments:
Budesonide